NCT03057288View on ClinicalTrials.gov

Prospective Study Evaluating the Feasibility of Fiducial Markers Placement for Patients With Esophageal or Rectal Cancer

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 3, 2017

Primary Completion Date

September 2, 2021

Study Completion Date

September 2, 2021

Conditions
Esophageal NeoplasmRectal Neoplasms
Interventions
DEVICE

fiducial markers placement

The main objective of this study is to evaluate the feasibility of fiducial markers placement under EUS guidance for patients with esophageal or rectal cancer with an indication of radiotherapy

Trial Locations (1)

75012

Ulriikka CHAPUT, Paris

All Listed Sponsors
collaborator

Cook Group Incorporated

INDUSTRY

lead

Société Française d'Endoscopie Digestive

OTHER

NCT03057288 - Prospective Study Evaluating the Feasibility of Fiducial Markers Placement for Patients With Esophageal or Rectal Cancer | Biotech Hunter | Biotech Hunter